Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Life Technologies; Agilent; Almac; NanoInk; Metabolon; Pressure BioSciences

NEW YORK (GenomeWeb News) – Life Technologies has assumed direct distribution of all Invitrogen products in Southern Africa, rather than selling through a third-party distributor. Andre Roberts, Life Tech's sales leader for Africa, said in the statement that the switch will provide customers with "shorter lead times and better access to our product range."

Agilent Technologies this week awarded Michael MacCoss of the University of Washington and Peter Park of Harvard University with its eMerging Insights grants. Each of the researchers will receive $75,000 to support their ongoing research into open-source data-integration tools. MacCoss is studying the integration of proteomic data with transcriptomic or metabolomics data sets, and Park is combining gene expression and copy number variation data.

Craigavon, UK-based Almac has opened a dedicated mass spectrometry lab at its European headquarters. The £1 million ($1.6 million)facility will provide a variety of services using the mass spec equipment, such as quantitation of genotoxic impurities, bioanalysis, and structure elucidation. The firm also said that it selected Agilent Technologies as its preferred vendor to supply the lab.

NanoInk said this week that BNM Fabrika will serve as exclusive distributor in Turkey for its desktop nanofabrication equipment.

Metabolon has opened a new metabolomics lab in Shanghai, China in collaboration with Shanghai Jiao Tong University. Research Triangle Park, NC-based Metabolon said that it has licensed its metabolomics platform to the university to enable a biochemical profiling lab there. The lab is funded by the university and personnel have been trained by Metabolon.

Pressure BioSciences announced that all remaining holders of its Series A and B Convertible Preferred Stock have voluntarily converted their shares into common stock of the firm. As a result, 3,453,140 shares of the company's common stock have been issued to the converting shareholders. The firm now has approximately 6.5 million shares of common stock outstanding.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.